These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 26666921)

  • 21. Transcriptomic analysis of colistin-susceptible and colistin-resistant isolates identifies genes associated with colistin resistance in Acinetobacter baumannii.
    Park YK; Lee JY; Ko KS
    Clin Microbiol Infect; 2015 Aug; 21(8):765.e1-7. PubMed ID: 25911992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.
    Kamoshida G; Yamada N; Nakamura T; Yamaguchi D; Kai D; Yamashita M; Hayashi C; Kanda N; Sakaguchi M; Morimoto H; Sawada T; Okada T; Kaya Y; Takemoto N; Yahiro K
    Microbiol Spectr; 2022 Oct; 10(5):e0192822. PubMed ID: 36173297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants.
    Bahador A; Taheri M; Pourakbari B; Hashemizadeh Z; Rostami H; Mansoori N; Raoofian R
    Microb Drug Resist; 2013 Oct; 19(5):397-406. PubMed ID: 23768166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virulence role of the outer membrane protein CarO in carbapenem-resistant
    Labrador-Herrera G; Pérez-Pulido AJ; Álvarez-Marín R; Casimiro-Soriguer CS; Cebrero-Cangueiro T; Morán-Barrio J; Pachón J; Viale AM; Pachón-Ibáñez ME
    Virulence; 2020 Dec; 11(1):1727-1737. PubMed ID: 33300460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates.
    Bardbari AM; Arabestani MR; Karami M; Keramat F; Alikhani MY; Bagheri KP
    Microb Pathog; 2017 Jul; 108():122-128. PubMed ID: 28457900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii.
    Durante-Mangoni E; Del Franco M; Andini R; Bernardo M; Giannouli M; Zarrilli R
    Diagn Microbiol Infect Dis; 2015 Jul; 82(3):222-6. PubMed ID: 25858028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii.
    Martínez-Guitián M; Vázquez-Ucha JC; Odingo J; Parish T; Poza M; Waite RD; Bou G; Wareham DW; Beceiro A
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4375-9. PubMed ID: 27139471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquisition of Tn6018-3' CS regions increases colistin MICs against Acinetobacter baumannii isolates harboring new variants of AbaRs.
    Savari M; Ekrami A; Shoja S; Bahador A
    Folia Microbiol (Praha); 2017 Sep; 62(5):373-379. PubMed ID: 28238067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii ST2 Clinical Isolate in Algeria: First Case Report.
    Bakour S; Olaitan AO; Ammari H; Touati A; Saoudi S; Saoudi K; Rolain JM
    Microb Drug Resist; 2015 Jun; 21(3):279-85. PubMed ID: 25588125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
    Ozbek B; Sentürk A
    Chemotherapy; 2010; 56(6):466-71. PubMed ID: 21088399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation of CarO participates in drug resistance in imipenem-resistant Acinetobacter baumannii.
    Zhu LJ; Chen XY; Hou PF
    J Clin Lab Anal; 2019 Oct; 33(8):e22976. PubMed ID: 31318107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.
    Bardbari AM; Arabestani MR; Karami M; Keramat F; Aghazadeh H; Alikhani MY; Bagheri KP
    Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):443-454. PubMed ID: 29353377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of biofilm formation in Acinetobacter baumannii isolates and their colistin susceptibilities in biofilm.
    Milletli Sezgin F; Coban AY; Gunaydin M
    Int J Antimicrob Agents; 2013 Feb; 41(2):199. PubMed ID: 23182537
    [No Abstract]   [Full Text] [Related]  

  • 34. Septal Class A Penicillin-Binding Protein Activity and ld-Transpeptidases Mediate Selection of Colistin-Resistant Lipooligosaccharide-Deficient Acinetobacter baumannii.
    Kang KN; Kazi MI; Biboy J; Gray J; Bovermann H; Ausman J; Boutte CC; Vollmer W; Boll JM
    mBio; 2021 Jan; 12(1):. PubMed ID: 33402533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel plasmid-encoded mcr-4.3 gene in a colistin-resistant Acinetobacter baumannii clinical strain.
    Martins-Sorenson N; Snesrud E; Xavier DE; Cacci LC; Iavarone AT; McGann P; Riley LW; Moreira BM
    J Antimicrob Chemother; 2020 Jan; 75(1):60-64. PubMed ID: 31578567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients.
    Vourli S; Frantzeskaki F; Meletiadis J; Stournara L; Armaganidis A; Zerva L; Dimopoulos G
    Int J Antimicrob Agents; 2015 Jun; 45(6):670-1. PubMed ID: 25795317
    [No Abstract]   [Full Text] [Related]  

  • 37. Enhancing effect of natural adjuvant, panduratin A, on antibacterial activity of colistin against multidrug-resistant Acinetobacter baumannii.
    Thadtapong N; Chaturongakul S; Napaswad C; Dubbs P; Soodvilai S
    Sci Rep; 2024 Apr; 14(1):9863. PubMed ID: 38684853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic and phenotypic studies of bicarinalin, BP100 and colistin action on Acinetobacter baumannii.
    Eales MG; Ferrari E; Goddard AD; Lancaster L; Sanderson P; Miller C
    Res Microbiol; 2018; 169(6):296-302. PubMed ID: 29751064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.